XAIR - Beyond Air® Schedules Fiscal Year End 2024 Financial Results Conference Call and Webcast | Benzinga
GARDEN CITY, N.Y., May 23, 2024 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ:XAIR) ("Beyond Air" or the "Company"), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders and solid tumors (through its affiliate Beyond Cancer, Ltd. ("Beyond Cancer")), today announced that it will report financial results for its fiscal fourth quarter and full year ended March 31, 2024 on Monday, June 24, 2024. The Company's management team is scheduled to host a conference call and webcast at 4:30 pm Eastern Time the same day.
| Conference Call & Webcast |
| Monday, June 24th @ 4:30 PM ET |
| Domestic: |
| 1-877-407-0784 |
| International: |
| 1-201-689-8560 |
| Conference ID: |
| 13746892 |
| Webcast: |
| A webcast of the live conference call can be accessed by visiting the Events section of the Company's website (click here) or directly (click here). An online replay will be available on the Company's website or via the direct link an hour after the call. |
About Beyond Air®, Inc.
Beyond Air ...